Wegovy vs Saxenda: Comparing Two GLP-1 Weight Loss Medications

If you're considering a GLP-1 medication for weight loss, you've likely come across both Wegovy and Saxenda. Both are FDA-approved injectable medications that work on similar pathways in your body, but they're not identical twins. Understanding the differences between these two options can help you have a more informed conversation with your healthcare provider about which might be the better fit for your goals.

Let's break down what makes each medication unique, how they compare in real-world results, and what you should consider when making this important health decision.

What Are Wegovy and Saxenda?

Both Wegovy and Saxenda belong to a class of medications called GLP-1 receptor agonists. They mimic a hormone your body naturally produces that helps regulate appetite and blood sugar levels.

Wegovy contains semaglutide, the same active ingredient found in Ozempic (which is FDA-approved for type 2 diabetes). It was specifically approved by the FDA for chronic weight management in 2021.

Saxenda contains liraglutide, an older GLP-1 medication that's been around since 2014 for weight loss. You might recognize liraglutide from Victoza, its counterpart approved for diabetes treatment.

Both medications are designed for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related condition like high blood pressure or type 2 diabetes.

How They Work in Your Body

While both medications activate GLP-1 receptors, they do so with different levels of intensity and duration.

Wegovy stays in your system longer, which is why it only requires a once-weekly injection. It works by slowing how quickly food leaves your stomach, reducing your appetite, and helping you feel fuller with smaller portions.

Saxenda has a shorter half-life, meaning it leaves your body more quickly. That's why you need to inject it daily to maintain consistent levels in your system. It works through the same mechanisms of appetite reduction and increased satiety.

The Gender Factor

Clinical trials for both medications included both men and women, though women made up the majority of participants. Some research suggests women may experience slightly different side effect profiles than men, particularly regarding nausea and gastrointestinal symptoms. However, both medications have shown effectiveness across genders, and your individual response matters more than population-level statistics.

Dosing Schedules: Weekly vs Daily

One of the most practical differences between these medications is how often you need to use them.

Wegovy starts at 0.25 mg once weekly and gradually increases over 16-20 weeks to a maintenance dose of 2.4 mg weekly. This slow titration helps minimize side effects as your body adjusts.

Saxenda requires daily injections, starting at 0.6 mg and increasing weekly until you reach the maintenance dose of 3 mg daily. You'll need to remember to inject every single day, ideally around the same time.

For many people, the convenience of weekly dosing makes Wegovy more appealing. Life is busy, and remembering a daily medication can be challenging. That said, some people prefer the daily routine because it feels more within their control.

Weight Loss Results: What the Research Shows

When it comes to effectiveness, the clinical trials reveal some meaningful differences.

In the STEP trials for Wegovy, participants lost an average of 15-17% of their body weight over 68 weeks when combined with lifestyle changes. Some participants lost even more, with nearly one-third losing 20% or more of their starting weight.

Saxenda trials showed an average weight loss of 5-10% of body weight over 56 weeks. While this is still clinically significant and can lead to meaningful health improvements, it's notably less than what's typically seen with Wegovy.

It's important to remember these are averages. Individual results vary based on starting weight, adherence to the medication, lifestyle factors, and your body's unique response.

Side Effects and Tolerability

Because both medications work on GLP-1 receptors, they share similar side effect profiles. The most common include nausea, diarrhea, constipation, vomiting, and abdominal discomfort.

With Wegovy, side effects tend to be most noticeable when you increase your dose. The weekly dosing means you get a larger amount at once, which some people find harder to tolerate initially.

Saxenda's daily dosing provides more consistent medication levels throughout the week, which may lead to more stable side effects, though you're experiencing them daily rather than having a few peak days each week.

Most side effects for both medications improve over time as your body adjusts. Eating smaller meals, avoiding fatty or spicy foods, and staying hydrated can help manage gastrointestinal symptoms.

Cost Considerations

Without insurance, both Wegovy and Saxenda carry substantial price tags, often exceeding $1,000 per month at retail prices.

Insurance coverage varies widely. Some plans cover one but not the other, while many still don't cover weight loss medications at all despite their FDA approval and proven health benefits.

This cost barrier has led many people to explore compounded semaglutide options, which can provide similar benefits at a more accessible price point.

Which One Might Be Right for You?

Choosing between Wegovy and Saxenda isn't about one being universally better than the other. It's about which aligns best with your lifestyle, medical history, and weight loss goals.

Wegovy might be preferable if you want the convenience of weekly dosing, are looking for potentially greater weight loss results, and can tolerate the once-weekly approach.

Saxenda could be the better choice if you prefer daily routines, want steadier medication levels throughout the week, or if your insurance covers it but not Wegovy.

Your doctor will also consider factors like your medical history, other medications you're taking, and any contraindications specific to your health situation.

From the Ozari Care Team

Whichever GLP-1 medication you choose, remember that it's a tool to support lifestyle changes, not replace them. We see the best outcomes in patients who combine medication with mindful eating practices, regular movement, adequate sleep, and stress management. The medication helps quiet food noise and reduce cravings, giving you the space to build sustainable habits that will serve you long-term.

Get Started with Affordable GLP-1 Treatment

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 28, 2026